4//SEC Filing
Abbott Matthew S 4
Accession 0001209191-23-035921
CIK 0001627223other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:46 PM ET
Size
8.9 KB
Accession
0001209191-23-035921
Insider Transaction Report
Form 4
Abbott Matthew S
VP, CAO & Controller
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-06-08−8,912→ 0 totalExercise: $14.43Exp: 2030-03-02→ Common Stock (8,912 underlying) - Exercise/Conversion
Common Stock
2023-06-08$14.43/sh+8,912$128,600→ 38,781.124 total - Sale
Common Stock
2023-06-08$34.20/sh−8,912$304,790→ 29,869.124 total
Footnotes (3)
- [F1]Includes directly owned shares, restricted stock units and dividend equivalent units.
- [F2]Shares were sold in multiple transactions at a price of $34.20.
- [F3]Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001786056
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:46 PM ET
- Size
- 8.9 KB